PrecisionMedNow

Precision Medicine Portal: Building a new taxonomy of disease focused on the individual

[PrecisionMedNow @PrecisionMedNow]

There is a strong debate about if #genomics analysis for #healthy people should be done or not. Important initiative from @BrighamWomens #hospital opening the #Preventive Genomics Clinics
https://t.co/4hXuo7025y

[PrecisionMedNow @PrecisionMedNow]

#FDA approves third #oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor: #NTRK fusions. See in @PrecisionMedNow #PrecisionMedicine portal
https://t.co/q6dOwXDjiN

[The Microbiome @The_Microbiome]

The study reveals differences in the tongue coating microbiome in patients with Pancreatic head carcinoma, liver cancer patients and healthy controls. #microbiome #metagenomics #16S

The #Microbiome Portal: https://t.co/SopPJCv6q7

[The Microbiome @The_Microbiome]

The study reveals the effect of Campylobacter jejuni on the development of colorectal cancer in mouse models @Gut_BMJ #microbiome #cancer #ColorectalCancer #metagenomics

New at The #Microbiome Portal: https://t.co/eHNqPH7wcS

[The Microbiome @The_Microbiome]

Review on how host-microbiome interactions might affect anticancer therapies @BioMedCentral

#microbiome #cancer #chemotherapy #immunotherapy #gutmicrobiome

#TheMicrobiomePortal: https://t.co/UW5ZefNr1x

[ClinGen @ClinGenResource]

New in #ClinVar - curated variants from the ClinGen CDH1 Expert Panel https://t.co/zYHiMdK7pj. Read "Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants" here https://t.co/I9grJhJjmf @NCBI_Clinical

[The Microbiome @The_Microbiome]

The authors summarize in this article the current state of the relations of urine and bladder microbiome and bladder cancer @PBajicMD @BJUIjournal #TheMicrobiomePortal: https://t.co/kdMRpCvgCD #biomarker #cancer #immunotherapy

[National Cancer Institute @theNCI]

If you are considering treatment for cancer, here are some possible questions you could ask your doctor: https://t.co/IF5OcxCvGT

[National Cancer Institute @theNCI]

Some older people diagnosed with acute myeloid leukemia (AML) now have two new treatment options, with recent approvals by the Food and Drug Administration: https://t.co/tkgc0oTVl4 #cancercurrents

[National Cancer Institute @theNCI]

The #CancerMoonshot is working to accelerate progress in cancer research, encourage collaboration, and improve the sharing of data, as Dr. Dinah Singer explains: https://t.co/kiPKljDttr

[National Cancer Institute @theNCI]

Almost all #cervicalcancers are caused by infection with high-risk types of the human papillomavirus (#HPV) https://t.co/1N3TUgUnEv #HPVaware

[National Cancer Institute @theNCI]

Vitamin D supplements don’t reduce the risk of developing cancer, according to results from a randomized trial: https://t.co/7n7IZVbQrU

[Eduardo Pareja @eduardopareja]

Congratulations @GenomicsEngland the best #genomics initiative in Europe completed !!
https://t.co/rt10FbEQq7

[Dr. Anthony Letai @NCIDirector]

Excited to see @US_FDA’s approval of #larotrectinib for adults & children with cancer whose tumors have specific TRK gene fusions. Promising treatment for a diversity of cancer types. And with such a development, important to highlight NCI’s long involvement.

[National Cancer Institute @theNCI]

What's happening with the #NCIMATCH precision medicine trial? The short answer is a lot, as NCI's Dr. Lyndsay Harris explains: https://t.co/BDe17RWhPT

[National Cancer Institute @theNCI]

A blood test called a #liquidbiopsy has shown promise for detecting genetic mutations in pediatric brain tumors: https://t.co/Xu80kO9IfZ #childhoodcancer

[National Cancer Institute @theNCI]

The #CancerMoonshot is working to accelerate progress in cancer research, encourage collaboration, and improve the sharing of data, as Dr. Dinah Singer explains: https://t.co/kiPKljDttr

[Eric Topol @EricTopol]

When #obesity turns out to be favorable ("paradox") for response to #cancer immunotherapy w/ PD-1 blockade
@NatureMedicine elegant study of immune system Δ across species, + outcomes in patients https://t.co/mSsQQOfN7i

[The Microbiome @The_Microbiome]

Mismatch repair status as a key predictor of the microbiome variance in colorectal #cancers #TheMicrobiomePortal https://t.co/hGZt0QjfBw @BioMedCentral @nicholas_l_chia

[National Cancer Institute @theNCI]

Tumor biopsies collected for research often don't have enough of the tumor tissue. A new study aims to change that: https://t.co/hpliPF4vUf @NCItreatment